Investigator Initiated Studies (IIS)
Roche’s Investigator Initiated Studies program funds and supports independent clinical research that advances scientific understanding in Roche’s areas of interest using their medicines.
Funder: Roche
Due Dates: Rolling (proposals accepted year-round)
Funding Amounts: Support varies by project scope; may include funding, study drug, materials, and/or information.
Summary: Supports investigator-initiated clinical studies that advance scientific and clinical knowledge in Roche’s areas of strategic interest.
Key Information: Open to US and non-US investigators; proposals must align with Roche’s strategic research areas.
Description
The Investigator Initiated Studies (IIS) program by Roche empowers researchers to independently design and conduct clinical studies. The program encourages innovative proposals that contribute to the scientific understanding of Roche medicines, improve patient care, and foster new ideas for disease-related research. IIS projects are initiated and managed by external sponsors, with Roche providing support in the form of funding, study drugs, and/or other resources, as allowed by local regulations. The program is open to a wide range of qualified sponsors, including academic centers, individual investigators, healthcare institutions, and government research organizations, both in the US and internationally.
